These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29773641)

  • 21. IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.
    Ågerstam H; Hansen N; von Palffy S; Sandén C; Reckzeh K; Karlsson C; Lilljebjörn H; Landberg N; Askmyr M; Högberg C; Rissler M; Porkka K; Wadenvik H; Mustjoki S; Richter J; Järås M; Fioretos T
    Blood; 2016 Dec; 128(23):2683-2693. PubMed ID: 27621309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD
    Jiang L; Zhao Y; Liu F; Huang Y; Zhang Y; Yuan B; Cheng J; Yan P; Ni J; Jiang Y; Wu Q; Jiang X
    Cell Commun Signal; 2024 Aug; 22(1):391. PubMed ID: 39113090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
    Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
    Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia.
    Yu Z; Du J; Hui H; Kan S; Huo T; Zhao K; Wu T; Guo Q; Lu N
    Theranostics; 2021; 11(1):93-106. PubMed ID: 33391463
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.
    Merhi F; Tang R; Piedfer M; Mathieu J; Bombarda I; Zaher M; Kolb JP; Billard C; Bauvois B
    PLoS One; 2011; 6(10):e25963. PubMed ID: 21998731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.
    Mulholland M; Depuydt MAC; Jakobsson G; Ljungcrantz I; Grentzmann A; To F; Bengtsson E; Jaensson Gyllenbäck E; Grönberg C; Rattik S; Liberg D; Schiopu A; Björkbacka H; Kuiper J; Bot I; Slütter B; Engelbertsen D
    Cardiovasc Res; 2024 May; 120(6):581-595. PubMed ID: 38563353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
    Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
    Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia.
    Kazi JU; Rönnstrand L
    Mol Oncol; 2013 Jun; 7(3):402-18. PubMed ID: 23246379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells.
    Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L
    PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.
    Nordigården A; Kraft M; Eliasson P; Labi V; Lam EW; Villunger A; Jönsson JI
    Blood; 2009 Mar; 113(10):2302-11. PubMed ID: 19064725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents.
    Dos Santos C; McDonald T; Ho YW; Liu H; Lin A; Forman SJ; Kuo YH; Bhatia R
    Blood; 2013 Sep; 122(11):1900-13. PubMed ID: 23896410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
    Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
    Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
    Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
    Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.
    Steinert G; Oancea C; Roos J; Hagemeyer H; Maier T; Ruthardt M; Puccetti E
    PLoS One; 2011; 6(7):e22540. PubMed ID: 21811629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.
    Zhang Y; Chen X; Wang H; Gordon-Mitchell S; Sahu S; Bhagat TD; Choudhary G; Aluri S; Pradhan K; Sahu P; Carbajal M; Zhang H; Agarwal B; Shastri A; Martell R; Starczynowski D; Steidl U; Maitra A; Verma A
    J Hematol Oncol; 2022 May; 15(1):70. PubMed ID: 35606824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor alpha (TNF alpha) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNF alpha receptors.
    Khoury E; Andre C; Pontvert-Delucq S; Drenou B; Baillou C; Guigon M; Najman A; Lemoine FM
    Blood; 1994 Oct; 84(8):2506-14. PubMed ID: 7522632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
    Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
    Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BEX1 acts as a tumor suppressor in acute myeloid leukemia.
    Lindblad O; Li T; Su X; Sun J; Kabir NN; Levander F; Zhao H; Lu G; Rönnstrand L; Kazi JU
    Oncotarget; 2015 Aug; 6(25):21395-405. PubMed ID: 26046670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.